Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient needles and herbs take on psoriasis in new trial

NCT ID NCT07410793

Disease control Sponsor: Mae Fah Luang University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two treatments for mild-to-moderate plaque psoriasis: acupuncture combined with a Chinese herbal cream versus acupuncture combined with a standard medicated cream (calcipotriol). About 28 adults with psoriasis on skin, scalp, or nails will be enrolled. Researchers will measure how well the skin clears and how much quality of life improves.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
acupuncture and Chinese herbal cream (Sophora flavescens, Cnidium monnieri, Prunus mume, Dictamnus dasycarpus, Rheum palmatum)
What this could lead to
If it works, this could point toward a natural, low-side-effect option to control mild-to-moderate plaque psoriasis.
What could go wrong
This is a small, early-phase trial with only 28 participants, so results may not apply to everyone. The herbal cream's effectiveness and safety are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Plaque psoriasis on skin, scalp, or nails * Not receive any psoriasis treatment at least 4 weeks prior to the study * ≤10% body surface area (BSA), PASI≤10, DLQI≤10 Exclusion Criteria: * Pregnancy and lactation * Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis * Uncontrollable diseases i.e. CVS, liver, kidney, cancer * Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin * Treated with psoriasis biologic agents in the past 6 months * Needle phobia * Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents * Participating in other clinical study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Plaque type psorisis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Plaque type psorisis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mae Fah Luang University

    RECRUITING

    Muang, Chiangrai, 57100, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.